Department of Cardiology, Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Shanghai 200032, China.
Department of Cardiology, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
J Mol Cell Cardiol. 2020 May;142:65-79. doi: 10.1016/j.yjmcc.2020.02.007. Epub 2020 Feb 20.
Reperfusion may cause injuries to the myocardium in ischemia situation. Emerging studies suggest that exosomes may serve as key mediators in myocardial ischemia/reperfusion (MI/R) injury.
The study was conducted to figure out the mechanism of M2 macrophage-derived exosomes (M2-exos) in MI/R injury with the involvement of microRNA-148a (miR-148a).
M2 macrophages were prepared and M2-exos were collected and identified. Neonatal rat cardiomyocytes (NCMs) were extracted for in vitro hypoxia/reoxygenation (H/R) model establishment, while rat cardiac tissues were separated for in vivo MI/R model establishment. Differentially expressed miRNAs in NCMs and H/R-treated NCMs after M2-exos treatment were evaluated using microarray analysis. The target relation between miR-148a and thioredoxin-interacting protein (TXNIP) was identified using dual luciferase reporter gene assay. Gain- and loss- of function studies of miR-148a and TXNIP were performed to figure out their roles in MI/R injury. Meanwhile, the activation of the TLR4/NF-κB/NLRP3 inflammasome signaling pathway and pyroptosis of NCMs were evaluated. M2 macrophages carried miR-148a into NCMs. Over-expression of miR-148a enhanced viability of H/R-treated NCMs, reduced infarct size in vivo, and alleviated dysregulation of cardiac enzymes and Ca overload in both models. miR-148a directly bound to the 3'-untranslated region (3'UTR) of TXNIP. Over-expressed TXNIP triggered the TLR4/NF-κB/NLRP3 signaling pathway activation and induced cell pyroptosis of NCMs, and the results were reproduced in in vivo studies.
This study demonstrated that M2-exos could carry miR-148a to mitigate MI/R injury via down-regulating TXNIP and inactivating the TLR4/NF-κB/NLRP3 inflammasome signaling pathway. This study may offer new insights into MI/R injury treatment.
再灌注可能会在缺血情况下导致心肌损伤。新出现的研究表明,外泌体可能是心肌缺血/再灌注(MI/R)损伤的关键介质。
本研究旨在探讨 M2 巨噬细胞衍生的外泌体(M2-exos)通过 microRNA-148a(miR-148a)在 MI/R 损伤中的作用机制。
制备 M2 巨噬细胞并收集和鉴定 M2-exos。提取新生大鼠心肌细胞(NCMs)建立体外缺氧/复氧(H/R)模型,分离大鼠心脏组织建立体内 MI/R 模型。采用微阵列分析评估 M2-exos 处理后 NCMs 及 H/R 处理后 NCMs 中差异表达的 miRNA。采用双荧光素酶报告基因检测鉴定 miR-148a 与硫氧还蛋白相互作用蛋白(TXNIP)的靶关系。通过 miR-148a 和 TXNIP 的功能获得和缺失研究,探讨它们在 MI/R 损伤中的作用。同时,评估 TLR4/NF-κB/NLRP3 炎性小体信号通路的激活和 NCMs 的细胞焦亡。M2 巨噬细胞将 miR-148a 带入 NCMs。miR-148a 的过表达增强了 H/R 处理的 NCMs 的活力,减少了体内的梗死面积,并缓解了两种模型中心脏酶的失调和 Ca 超载。miR-148a 直接与 TXNIP 的 3'非翻译区(3'UTR)结合。过表达的 TXNIP 触发 TLR4/NF-κB/NLRP3 信号通路的激活,并诱导 NCMs 的细胞焦亡,在体内研究中也得到了重现。
本研究表明,M2-exos 可通过下调 TXNIP 并抑制 TLR4/NF-κB/NLRP3 炎性小体信号通路来携带 miR-148a 减轻 MI/R 损伤。这项研究可能为 MI/R 损伤的治疗提供新的思路。